Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07750002
NA

NVTIA® Ergothioneine for Healthy Aging and Skin Health

Sponsor: EUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION

View on ClinicalTrials.gov

Summary

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of NVTIA® Ergothioneine, a branded ergothioneine ingredient, on healthy aging biomarkers and skin health in healthy adults aged 40 to 65 years. Participants will receive either NVTIA® Ergothioneine or a matching placebo once daily for 12 weeks. The primary objective of this study is to evaluate the effects of NVTIA® Ergothioneine supplementation on biomarkers associated with oxidative stress and healthy aging. Secondary objectives include assessment of skin elasticity, skin hydration, inflammatory biomarkers, and overall safety. The findings of this study are expected to provide clinical evidence supporting the role of NVTIA® Ergothioneine in promoting healthy aging and maintaining skin health.

Official title: A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of NVTIA® Ergothioneine Supplementation on Healthy Aging Biomarkers and Skin Health in Healthy Adults

Key Details

Gender

All

Age Range

35 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-08-15

Completion Date

2027-04-08

Last Updated

2026-08-06

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

NVTIA® Ergothioneine

NVTIA® Ergothioneine is a standardized branded ergothioneine ingredient manufactured under controlled quality standards for use as a dietary supplement.

OTHER

Placebo

Matching placebo capsules identical in appearance, color, size, and packaging to the investigational product. One capsule will be administered orally once daily for 12 weeks.

Locations (1)

Dhaka Central International Medical College & Hospital

Dhaka, Bangladesh